title: Toll-like receptors regulate B cell cytokine production in patients with diabetes.
abstract: OBJECTIVE
  Understanding cellular and molecular events in diabetes mellitus will identify new approaches for therapy. Immune system cells are important modulators of chronic inflammation in diabetes mellitus, but the role of B cells is not adequately studied. The aim of this work was to define the function of B cells in diabetes mellitus patients through focus on B cell responses to pattern recognition receptors.
  
  
  METHODS
  We measured expression and function of Toll-like receptors (TLRs) on peripheral blood B cells from diabetes mellitus patients by flow cytometry and multiplexed cytokine analysis. We similarly analysed B cells from non-diabetic donors and periodontal disease patients as comparative cohorts.
  
  
  RESULTS
  B cells from diabetes mellitus patients secrete multiple pro-inflammatory cytokines, and IL-8 production is significantly elevated in B cells from diabetic patients compared with those from non-diabetic individuals. These data, plus modest elevation of TLR surface expression, suggest B cell IL-8 hyperproduction is a cytokine-specific outcome of altered TLR function in B cells from diabetes mellitus patients. Altered TLR function is further evidenced by demonstration of an unexpected, albeit modest 'anti-inflammatory' function for TLR4. Importantly, B cells from diabetes mellitus patients fail to secrete IL-10, an anti-inflammatory cytokine implicated in inflammatory disease resolution, under a variety of TLR-stimulating conditions. Comparative analyses of B cells from patients with a second chronic inflammatory disease, periodontal disease, indicated that some alterations in B cell TLR function associate specifically with diabetes mellitus.
  
  
  CONCLUSIONS
  Altered TLR function in B cells from diabetes mellitus patients increases inflammation by two mechanisms: elevation of pro-inflammatory IL-8 and lack of anti-inflammatory/protective IL-10 production.
authors.affiliation: Department of Pathology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Jagannathan
authors.forename: M
authors.initials: M
authors.lastname: McDonnell
authors.forename: Y
authors.initials: Y
authors.lastname: Liang
authors.forename: H
authors.initials: H
authors.lastname: Hasturk
authors.forename: J
authors.initials: J
authors.lastname: Hetzel
authors.forename: D
authors.initials: D
authors.lastname: Rubin
authors.forename: A
authors.initials: A
authors.lastname: Kantarci
authors.forename: T E
authors.initials: TE
authors.lastname: Van Dyke
authors.forename: L M
authors.initials: LM
authors.lastname: Ganley-Leal
authors.forename: B S
authors.initials: BS
authors.lastname: Nikolajczyk
mesh_terms: D000328:Adult; D000368:Aged; D001402:B-Lymphocytes / Q000378:metabolism*; D016207:Cytokines / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000276:immunology / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000276:immunology / Q000378:metabolism; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D016753:Interleukin-10 / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D051193:Toll-Like Receptors / Q000378:metabolism*
chemical_list: D016207:Cytokines; D016209:Interleukin-8; D051193:Toll-Like Receptors; D016753:Interleukin-10
references.citation: Circulation. 2004 Jul 27;110(4):380-5
references.pmid: 15262834
references.citation: J Immunol. 2009 Dec 1;183(11):7461-70
references.pmid: 19917698
references.citation: J Biol Chem. 1991 Oct 15;266(29):19490-8
references.pmid: 1918061
references.citation: Jpn Heart J. 2003 Jul;44(4):451-61
references.pmid: 12906027
references.citation: Diabetes. 2002 May;51(5):1596-600
references.pmid: 11978661
references.citation: J Immunol. 2007 May 15;178(10):6092-9
references.pmid: 17475834
references.citation: J Immunol. 2002 May 1;168(9):4531-7
references.pmid: 11970999
references.citation: J Periodontol. 2008 Aug;79(8 Suppl):1527-34
references.pmid: 18673007
references.citation: BMC Med Genet. 2008 Feb 25;9:9
references.pmid: 18298826
references.citation: BMC Immunol. 2008 Jul 24;9:39
references.pmid: 18652679
references.citation: Nat Med. 2009 Aug;15(8):921-9
references.pmid: 19633657
references.citation: J Leukoc Biol. 2009 Oct;86(4):1007-16
references.pmid: 19589946
references.citation: Diabetes. 2003 Mar;52(3):812-7
references.pmid: 12606524
references.citation: Nat Med. 2009 Aug;15(8):930-9
references.pmid: 19633656
references.citation: J Diabetes Complications. 2010 May-Jun;24(3):192-8
references.pmid: 19395279
references.citation: Diabetes. 2005 Dec;54 Suppl 2:S11-7
references.pmid: 16306328
references.citation: Infect Immun. 2004 Sep;72(9):5041-51
references.pmid: 15321997
references.citation: Diabetes Care. 2010 Apr;33(4):861-8
references.pmid: 20067962
references.citation: Diabetes. 2007 Aug;56(8):1986-98
references.pmid: 17519423
references.citation: Blood. 2003 Aug 1;102(3):956-63
references.pmid: 12689944
references.citation: Nature. 1997 Oct 9;389(6651):610-4
references.pmid: 9335502
references.citation: Immunity. 2010 Jan 29;32(1):129-40
references.pmid: 20079667
references.citation: Ann N Y Acad Sci. 2004 Dec;1037:170-4
references.pmid: 15699513
references.citation: Nat Med. 2009 Aug;15(8):914-20
references.pmid: 19633658
references.citation: J Clin Invest. 2006 Nov;116(11):3015-25
references.pmid: 17053832
references.citation: J Biol Chem. 2006 Sep 15;281(37):26865-75
references.pmid: 16798732
references.citation: J Immunol. 2008 Apr 1;180(7):4763-73
references.pmid: 18354200
references.citation: Diabetologia. 2007 Jun;50(6):1267-76
references.pmid: 17426960
references.citation: J Leukoc Biol. 2009 Apr;85(4):648-55
references.pmid: 19118102
references.citation: Clin Immunol. 2006 Sep;120(3):272-84
references.pmid: 16766226
references.citation: Diabetes. 1996 Jul;45(7):881-5
references.pmid: 8666137
references.citation: Diabetes. 2002 Apr;51(4):1088-92
references.pmid: 11916930
references.citation: Am J Physiol Endocrinol Metab. 2007 Mar;292(3):E740-7
references.pmid: 17090751
references.citation: J Periodontal Res. 1991 May;26(3 Pt 2):230-42
references.pmid: 1679130
references.citation: Horm Metab Res. 2000 Nov-Dec;32(11-12):537-41
references.pmid: 11246821
references.citation: N Engl J Med. 2007 Apr 12;356(15):1517-26
references.pmid: 17429083
references.citation: Arthritis Rheum. 2003 Mar;48(3):839-45
references.pmid: 12632440
references.citation: J Immunol. 2001 Oct 15;167(8):4494-503
references.pmid: 11591776
references.citation: Nature. 2002 Apr 11;416(6881):603-7
references.pmid: 11948342
references.citation: J Endocrinol. 2008 Dec;199(3):399-406
references.pmid: 18787058
references.citation: Ann Periodontol. 1999 Dec;4(1):1-6
references.pmid: 10863370
references.citation: J Immunol. 2004 Mar 15;172(6):3422-7
references.pmid: 15004141
references.citation: Diabetes. 2003 Jul;52(7):1799-805
references.pmid: 12829649
references.citation: Periodontol 2000. 2007;44:127-53
references.pmid: 17474930
references.citation: Nat Immunol. 2002 Oct;3(10):944-50
references.pmid: 12244307
references.citation: Lancet. 2006 Feb 25;367(9511):668-78
references.pmid: 16503465
references.citation: Vitam Horm. 2006;74:443-77
references.pmid: 17027526
references.citation: Eur J Clin Invest. 2004 Sep;34(9):641-2
references.pmid: 15379764